Virologix Corporation is categorized under Commercial Research Laboratory in Dallas, TX and active since 2001.
Virologix Corporation was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Research Laboratory business, which does work in the B2B market, and is classified as a Commercial Research Laboratory, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Rosemary Mazamet at the company’s single location by writing to 2600 North Stemmons Freeway, Dallas, Texas TX 75207 or by phoning (214) 905-5100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Virologix Corporation |
| Contact Person: | Rosemary Mazamet |
| Address: | 2600 North Stemmons Freeway, Dallas, Texas 75207 |
| Phone Number: | (214) 905-5100 |
| Website Address: | accesspharma.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Research Laboratory |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Virologix Corporation was started in 2001 to provide professional Commercial Research Laboratory under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Rosemary Mazamet for inquiries that concern Virologix Corporation by calling the company number (214) 905-5100, as your correspondence is most welcome. Additionally, the physical location of the single location of Virologix Corporation can be found at the coordinates 32.807321,-96.840504 as well as the street address 2600 North Stemmons Freeway in Dallas, Texas 75207.
For its online presence, you may visit Virologix Corporation’s website at accesspharma.com and engage with its social media outlets through on Twitter and on Facebook.